The company offers a telemedicine care system and genetic testing services that use advances in science, technology, and computational analytics to provide ALS patients with access to personalized treatments. Synapticure was created by patient and caregiver advocates, along with ALS clinicians, biotech executives, and telemedicine executives, to bring the ALS care and treatment experience into the 21st century. The company's goal is to ensure that all ALS patients have access to the best clinics, testing, and treatment options, and to improve the outcome of the disease.